HanlonT. M., BinkiewiczA., FinegoldM., and NechelesT. F.: Procainamide Hydrochloride Induced Lupus Syndrome in a Child with Myotonia Congenita, Amer. J. Dis. Child.113: 491, 1967.
13.
DuboisE. L.: Procainamide Induction of a Systemic Lupus Erythematosus-Like Syndrome, Medicine48: 217, 1969.
14.
SwarbrickE. T., and IanR. Gray.: Systemic Lupus Erythematosus During Treatment with Procainamide, Brit. Heart J.34: 284–288, 1972.
15.
BlomgrenS. E., CondemiJ. J., and VaughanJ. H.: Procainamide-Induced Lupus Erythematosus. Clinical and Laboratory Observations, Amer. J. Med.52: 338–348, 1972.
16.
MolinaJ., and DuboisE. L.: Procainamide-Induced Serological Changes in Asymptomatic Patients, Arthritis Rheumatism12: 608 (Dec.) 1969.
17.
RussellA. S., and ZiffM.: Natural Antibodies to Procainamide, Clin. Exp. Immunol.3: 901, 1968.
18.
KlajamA., Camin-BelskyN., KimehiA., and Ben-EfraimS.: Occurrence, Immuno-Globulin Pattern and Specificity of Antinuclear Antibodies in Sera of Procainamide Treated Patients, Clin. Exp. Immunol.7: 641–649, 1970.
19.
BlomgrenS. E., CondemiJ. J., BienallM. C., and Vaugham: Antinuclear Antibody Induced by Procainamide. A Prospective Study, N. E. J. Med.281: 64, 1969.
20.
PetersonR. D. A., and GoodR. A.: Interrelationships of Mesenchymal Diseases with Consideration of Possible Genetic Mechanisms, Ann. Rheum. Med.14: 1, 1963.
21.
SheldonP. J. H. S., and WilliamsW. R.: Procainamide-Induced Systemic Lupus Erythematosus, Ann. Rheum. Dis.29: 236, 1970.
22.
RosinJ. M.: Vasculitis Following Procainamide Therapy, Amer. J. Med.42: 625, 1967.
23.
RussellA. S., and Ziff: Natural Antibodies to Procainamide, Clin. Exp. Immunol.3: 901, 1968.
24.
BlomgrenS. A., and VaughamJ. H.: The immunogenicity of Photo-Oxidized DNA and of the Photo-Product of DNA and Procainamide Hydrochloride, Arthritis and Rheum.11: 470, 1968.
25.
Alarcón-SegoviaD.: Drug-Induced Lupus Syndromes, Proc. Staff Mayo Clinic44: 664, 1969.
26.
Van VunakisH., SeamanE., KahanL.: Formulation of an Adduct with Tris (Hydroxymethyl) Amino Methane During the Photo-Oxydation of Deosy-Ribo-Nucleic Acid and Guanine Derivatives, Biochemistry5: 3986, 1966.
27.
Alarcón-SegoviaD., WakinK. G., WorthingtonJ. W., and WardL. E.: Clinical and Experimental Studies on the Hydralazine Syndrome and its Relationship to Systemic Lupus Erythematosus, Medicine46: 1, 1967.
AnastassiadesT. P., and MilukenJ. A.: Lupus-Like Syndrome, with Persistent Immunological Abnormalities, Related to Procainamide Therapy, C.M.A. J.107: 312, 1972.
30.
DuboisE. L.: Personal Communication, 1973.
31.
MiescherP., ThomasL., and BenacerrafB.: The Immunopathology of Lupus Erythematosus, Brit. J. Derm.72: 221–230 (June) 1960.
